Trishna Goswami
Chief Tech/Sci/R&D Officer at IN8BIO, INC.
Net worth: 5 693 $ as of 2024-06-29
Network origin in Trishna Goswami first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Biotechnology | 26 | |
14
| Public Company | Biotechnology | 14 |
| Subsidiary | Pharmaceuticals: Major | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Trishna Goswami via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| CELGENE | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Director of Finance/CFO Compliance Officer Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| SEAGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Director/Board Member Sales & Marketing | |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Pharmaceuticals: Other | Public Communications Contact Corporate Secretary | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO General Counsel Chief Operating Officer | |
| University of Virginia | College/University | Undergraduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
| MIRATI THERAPEUTICS | Biotechnology | Chief Executive Officer | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Doctorate Degree Masters Business Admin Masters Business Admin | |
| State University of New York at Albany | College/University | Undergraduate Degree Undergraduate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Graduate Degree Undergraduate Degree | |
| ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Amgen Europe BV
 Amgen Europe BV Medical DistributorsDistribution Services Part of Amgen, Inc., Amgen Europe BV wholesales pharmaceutical products. The company is based in Breda, Netherlands. | Medical Distributors | Corporate Officer/Principal | |
| CLOVIS ONCOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member | |
| FORTY SEVEN, INC. | Pharmaceuticals: Major | President Director/Board Member | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member | |
| The University of North Carolina at Charlotte | College/University | Doctorate Degree Graduate Degree | |
| United States Court of Appeals For The Fourth Circuit | Corporate Officer/Principal | ||
| JOUNCE THERAPEUTICS, INC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| AXCA HEALPAR | Biotechnology | Director/Board Member Private Equity Investor | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| JUNO THERAPEUTICS INC | Biotechnology | Corporate Officer/Principal | |
| Washington University School of Medicine | College/University | Doctorate Degree | |
Frontier Equities VC LLC
 Frontier Equities VC LLC Investment ManagersFinance Frontier Equities VC LLC (Frontier Equities) is a venture capital firm founded in 2011 by Mark Sard. The firm is headquartered in New York, United States. | Investment Managers | Founder | |
| PMV PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Director/Board Member | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Aadi Subsidiary, Inc.
 Aadi Subsidiary, Inc. BiotechnologyHealth Technology Aadi Subsidiary, Inc. engages in biopharmaceutical company. Its therapeutic programs include pulmonary arterial hypertension, pediatric solid tumors, solid tumors with mTOR activation and mitochondrial disease. The company was founded by Neil Desai and is headquartered in Pacific Palisades, CA. | Biotechnology | Director/Board Member Chief Executive Officer | |
Gilead Sciences Ltd.
 Gilead Sciences Ltd. Medical DistributorsDistribution Services Founded in 1990, Gilead Sciences Ltd. is a pharmaceutical wholesaler that is part of Gilead Sciences, Inc. The company is based in London, UK and specializes in the distribution of pharmaceutical products. | Medical Distributors | Director/Board Member Director/Board Member | |
| AUTOLUS THERAPEUTICS PLC | Biotechnology | Director/Board Member Director/Board Member | |
Oncomyx Therapeutics, Inc.
 Oncomyx Therapeutics, Inc. Packaged SoftwareTechnology Services Oncomyx Therapeutics, Inc. develops and operates software platform to orchestrate an immune response and treat cancer. Its platform's features include non-human pathogen, immuno-stimulatory, ability to multi-arm, and systemic delivery. The company was founded by Steve Potts, Michael Wood, Grant McFadden and is headquartered in Phoenix, AZ. | Packaged Software | Chairman | |
| ACRIVON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Odyssey Therapeutics, Inc.
 Odyssey Therapeutics, Inc. Packaged SoftwareTechnology Services Odyssey Therapeutics, Inc. is a biotechnology company that specializes in discovering, developing, and commercializing immunomodulators and oncology medicines. The company is based in Medfield, MA and has subsidiaries in the United Kingdom. The company is composed of a team of drug hunters, scientists, and industry leaders in foundational biology, chemistry, and data sciences. Odyssey Therapeutics aims to transform drug discovery to accelerate and drive the creation and efficient delivery of life-enhancing precision medicines to patients. Odyssey Therapeutics was founded by David L. Pompliano, Gary D. Glick, and Melissa Merrick, with Gary D. Glick serving as the CEO since incorporation. | Packaged Software | Director/Board Member | |
| AADI BIOSCIENCE, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| Daniel M. Hume, M.D. PA | President | ||
Terremoto Biosciences, Inc.
 Terremoto Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Terremoto Biosciences, Inc. is a drug discovery and development company that creates highly targeted, small molecule medicines with unmatched selectivity, potency, and efficacy to deliver superior therapeutic benefit to patients. The company is based in San Francisco, CA. Terremoto is supported by leading investors, including OrbiMed, Third Rock Ventures, EcoR1 Capital, Novo Holdings, and Cormorant Capital. The company aims to expand the universe of drug targets and improve existing medicines by unleashing the power of covalent chemistry. Terremoto was founded by Peter A. Thompson and Matthew P. Jacobson, and Peter A. Thompson has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
Lirum Therapeutics, Inc.
 Lirum Therapeutics, Inc. BiotechnologyHealth Technology Lirum Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the treatment of deliberating diseases. The firm is also involved in the acquisition, development, and commercialization of drug candidates. Its products include LX-101, a targeted therapy directed to the insulin-like growth factor 1 (IGF-1R). The company was founded in November 2021 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
Mallinckrodt LLC
 Mallinckrodt LLC Pharmaceuticals: MajorHealth Technology Mallinckrodt LLC is proud to be one of the world's largest suppliers of both controlled substance pain medication and acetaminophen and to have over a century of leadership in helping to diagnose disease through imaging procedures. They are focused on innovative research and development programs, strong clinician relationships and a collaborative approach to new business opportunities. In short, they aim to lead a new generation of patient care by pursuing better, safer, more cost effective ways of diagnosing and treating disease to improve patient outcomes. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Director of Finance/CFO Director/Board Member |
Statistics
International
| United States | 46 |
| United Kingdom | 4 |
| Germany | 2 |
| Netherlands | 2 |
Sectoral
| Health Technology | 27 |
| Consumer Services | 14 |
| Distribution Services | 3 |
| Commercial Services | 3 |
| Finance | 3 |
Operational
| Director/Board Member | 198 |
| Corporate Officer/Principal | 102 |
| Independent Dir/Board Member | 63 |
| Undergraduate Degree | 39 |
| Chief Executive Officer | 25 |
Most connected contacts
| Insiders | |
|---|---|
| Peter Hutt | 69 |
| Luba Greenwood | 32 |
| Khalid Islam | 29 |
| Barbara Duncan | 22 |
| Alan Roemer | 21 |
| Scott Canute | 17 |
| Brett Pletcher | 15 |
| Robert Azelby | 15 |
| Darren Cline | 15 |
| Daniel Hume | 14 |
| Andrew Dickinson | 13 |
| Loretta Itri | 12 |
| Charles Baum | 12 |
| Behzad Aghazadeh | 12 |
| Robert Iannone | 12 |
- Stock Market
- Insiders
- Trishna Goswami
- Company connections
